Showing 8201-8210 of 20875 results for "".
Newt Gingrich: Improving Care for Diabetics
https://reachmd.com/programs/clinicians-roundtable/newt-gingrich-improving-care-for-diabetics/1338/Perhaps best known for his Contract with America and the subsequent Republican control of the House of Representatives for 12 years, many physicians do not know how strong a healthcare advocate former Speaker of the House Newt Gingrinch has become, or the tranformations in health policy he began pioAssessing Glucose Control & Reducing Cardiovascular Risk in Patients with Diabetes
https://reachmd.com/programs/diabetes-discourse/assessing-glucose-control-reducing-cardiovascular-risk-in-patients-with-diabetes/12769/Could glucose control mitigate cardiovascular risk in diabetic patients?A New Health Plan to Eliminate Diabetes Patients’ Out-of-Pocket Costs
https://reachmd.com/programs/the-drug-report/a-new-health-plan-to-eliminate-diabetes-patients-out-of-pocket-costs/11286/CVS Health recently announced a new plan to eliminate out-of-pocket costs associated with diabetes prescription medicines. Here are the details.How Low Carb Diets Enhance Gestational Diabetes Control
https://reachmd.com/programs/nutritionedge/how-low-carb-diets-enhance-gestational-diabetes-control/7674/Controlling blood sugar and weight gain in expectant patients with gestational diabetes can be challenging. But the move toward lower carbohydrate diets for these patients has shown promise in controlling diabetic progression through pregnancy. Joining host Kathy King to discuss the mechanisms and rAdvances in Continuous Glucose Monitoring
https://reachmd.com/programs/diabetes-discourse/advances-in-continuous-glucose-monitoring/5341/Continuous glucose monitoring is an effective tool in the management of both type 1 diabetes and insulin-requiring type 2 diabetes patients. However, barriers and challenges remain for both the healthcare provider and patient. Join host Dr. Steven Edelman and his guest, director of the Advanced MetaEvolocumab in Patients Without Significant Atherosclerosis and With Diabetes: A Cardiology Perspective on VESALIUS-CV
https://reachmd.com/clinical-practice/cardiology/evolocumab-in-patients-without-significant-atherosclerosis-and-with-diabetes-a-cardiology-perspective-on-vesalius-cv/56744/New VESALIUS-CV data show broad cardiovascular benefits of evolocumab in high-risk primary prevention patients with diabetes and no atherosclerosis.Political Solutions for the Diabetes Pandemic
https://reachmd.com/programs/clinicians-roundtable/political-solutions-for-the-diabetes-pandemic/1782/Dr. Maurice Pickard discusses with Dr. Nigel Unwin the need for governments to create an environment that allows individuals to make lifestyle changes. The adoption of western culture's poor dietary habits and reduced exercise lifestyles, as well as expanding urban environments fostering these shifManaging Erectile Dysfunction Stemming from Diabetes and Heart Disease
https://reachmd.com/programs/clinicians-roundtable/managing-erectile-dysfunction-stemming-from-diabetes-heart-disease/8035/Dr. Charles Walker discusses erectile dysfunction as a common complication for patients dealing with diabetes and heart disease, and how to manage it.Semaglutide Reduces CV Events in Non-Diabetic, Overweight Patients
https://reachmd.com/programs/diabetes-discourse/semaglutide-reduces-cv-events-in-non-diabetic-overweight-patients/18109/Tune in to find out how semaglutide affects cardiovascular outcomes in patients who are overweight or obese, but do not have diabetes.No Patient With CKD Left Behind: New Horizons in Patients With CKD Regardless of Diabetes Status
https://reachmd.com/programs/cme/no-patient-with-ckd-left-behind-new-horizons-in-patients-with-ckd-regardless-of-diabetes-status/49260/Explore emerging evidence for nonsteroidal MRAs in chronic kidney disease and implications for patients with and without diabetes.